Mark L. Jacobson, Chief Operating Officer at Axsome Therapeutics, Inc. (AXSM), sold 4,750 shares at $227.94 ($1.1M) on 2026-05-04, disclosed to the SEC on 2026-05-05.
Scheduled sale ($1.1M) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $227.94 | 4,517 | $1.0M | 95.1% |
| 2 | $228.18 | 233 | $53K | 4.9% |
| Total | $227.95 avg | 4,750 | $1.1M | 100% |
| Filing → |
| AXSM | SELL | 2025-09-22 | $1.2M | — | Filing → |
| AXSM | SELL | 2025-09-17 | $5.9M | — | Filing → |
| AXSM | SELL | 2025-06-10 | $2.8M | — | Filing → |